TG-100-344

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTG-100-344
Drug Alias NameProtein Kinase Inhibitor (TargeGen)TG-100-344
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor receptorVascular endothelial growth factor A
Therapy Area/IndicationsMacular DegenerationEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTargegen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargegen Inc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A